Clinical Trial Update: Korean Post-marketing Surveillance for Orencia®

View source ↗

Summary

The document reports the completion of a Korean post-marketing surveillance study of Orencia (abatacept) for rheumatoid arthritis. It indicates the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: COMPLETED